Prevalence and patterns of methylphenidate use in French children and adolescents-Reference-Cited by-同舟云学术

Prevalence and patterns of methylphenidate use in French children and adolescents

Published:2007-11-20 Issue:3 Volume:64 Page:311-317
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Knellwolf Anne-Laure,Deligne Jean,Chiarotti Flavia,Auleley Guy-Robert,Palmieri Serena,Boisgard Claudine Blum,Panei Pietro,Autret-Leca Elisabeth

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00228-007-0401-6.pdf

Reference34 articles.

1. Wong ICK, Murray ML, Camilleri-Novak D, Stephens P (2004) Increased prescribing trends of paediatric psychotropic medications. Arch Dis Child 89:1131–1132

2. Bonati M, Clavenna A (2005) The epidemiology of psychotropic drug use in children and adolescents. Int Rev Psychiatry 17:181–188

3. Scheffler RM, Hinshaw SP, Modrek S, Levine P (2007) The global market for ADHD medications. Health Affairs 26:450–457

4. National Institute for Health and Clinical Excellence NICE Technology (Appraisal 98. Issue March 2006). Methylphenidate, atomoxetine and dexamfetamine for attention deficit hyperactivity disorder (ADHD) in children and adolescents. Available at: http://www.nice.org.uk

5. Safer DJ, Malever M (2000) Stimulant treatment in Maryland public schools. Pediatrics 106:533–539

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence rate of ADHD in France: Review of the literature and results from ChiP-ARD study;L'Encéphale;2023-12

2. ADHD diagnosis and methylphenidate consumption in children and adolescents: A systematic analysis of health databases in France over the period 2010–2019;Frontiers in Psychiatry;2022-10-10

3. Impasses des approches biomédicales, nécessité de la psychanalyse : le cas de l’hyperactivité/TDAH;À l’écoute des enfants hyperactifs;2022-09-20

4. Medicine and supplement use in infants, children, and adolescents depends on sex, age, and socioeconomic status: results of a German longitudinal population-based cohort study (LIFE Child);European Journal of Pediatrics;2022-05-26

5. La prescription de méthylphénidate chez l’enfant et l’adolescent en France : caractéristiques et évolution entre 2010 et 2019;Neuropsychiatrie de l'Enfance et de l'Adolescence;2022-05